Managing erythema multiforme involves a careful balance of symptom relief and addressing the underlying triggers that cause this distinctive skin reaction, whether it stems from an infection, a medication, or another source. Understanding the available treatment approaches helps patients and healthcare providers work together to minimize discomfort and prevent future episodes.

Navigating Treatment Options for This Skin Condition

When erythema multiforme appears—characterized by its distinctive target-shaped rash—the primary goals of treatment focus on relieving uncomfortable symptoms, addressing the condition that triggered the reaction, and preventing recurrence when possible. Treatment approaches differ based on whether a person has the minor or major form of the condition, with more intensive care needed for cases involving mucous membranes or widespread skin involvement.^[1]

Most cases of erythema multiforme (a skin reaction causing distinctive target-shaped lesions) are self-limiting, meaning they resolve on their own without major complications. The condition typically improves within two to four weeks. However, during this time, appropriate management can significantly reduce discomfort and speed recovery. Treatment decisions are guided by the severity of symptoms, the extent of skin and mucous membrane involvement, and whether an underlying cause can be identified and treated.^[3]

The stage and characteristics of the disease play a crucial role in determining the most appropriate treatment path. For instance, someone with erythema multiforme minor—where only the skin is affected with limited rash and no involvement of the mouth, eyes, or genitals—may need only simple symptomatic care at home. In contrast, erythema multiforme major, which involves painful blistering of mucous membranes and can make eating, drinking, or seeing difficult, may require hospital admission for supportive care including intravenous fluids and nutritional support.^[1]

Standard Treatment Approaches

The foundation of treating erythema multiforme lies in identifying and eliminating the trigger whenever possible. If a medication is suspected as the cause, healthcare providers typically recommend stopping that medication immediately. This includes any drugs started within the two months before the rash appeared. It’s essential that patients never stop taking prescribed medications without consulting their doctor first, as abrupt discontinuation of some medicines can cause other health problems.^[3]

When an infection is identified as the trigger, appropriate antimicrobial treatment is initiated. For example, if bacterial pneumonia caused by Mycoplasma pneumoniae (a type of bacteria that causes lung infections) is detected, antibiotics are prescribed. If blood tests or cultures reveal a viral infection like herpes simplex virus (HSV, a common virus that causes cold sores), antiviral medications may be considered. However, it’s important to understand that antiviral treatment started after the erythema multiforme rash has already erupted does not change the course of the current episode—it only helps prevent future occurrences in recurrent cases.^[6][9]

For symptom relief, several approaches are commonly used. Topical corticosteroids (steroid creams or ointments applied directly to the skin) help reduce inflammation and itching. These are particularly useful for patients with limited skin involvement who can be managed as outpatients. The steroids work by dampening the immune response that causes the redness and swelling. Moisturizers also play an important role in keeping the skin hydrated and promoting healing.^[3][9]

Antihistamines (medications that block histamine, a substance released during allergic reactions) can help control itching, though they don’t address the underlying inflammation directly. Cold compresses applied to affected areas provide additional comfort. Some healthcare providers recommend using saline solution or Burrow solution (an astringent liquid) for compresses, which can soothe irritated skin.^[9]

The use of systemic corticosteroids (steroid medications taken by mouth or intravenously that affect the whole body) remains controversial in treating erythema multiforme. Some medical experts believe that steroids given for the whole body may increase the risk of complications or prolong healing in certain situations. When systemic steroids are prescribed, they are typically limited to a short course of 10 days to two weeks to minimize potential side effects such as increased blood sugar, mood changes, weight gain, or susceptibility to infections.^[9]

For patients with significant mucous membrane involvement, particularly affecting the eyes, urgent ophthalmologic consultation is essential. Eye involvement can lead to serious complications if not properly managed. Topical lubricants help with dry eyes, and healthcare providers may need to sweep the conjunctival fornices (the spaces between the eyelid and eyeball) and remove fresh adhesions to prevent permanent scarring. Antibiotic solutions or ointments may be applied to prevent secondary bacterial infections.^[8][9]

Preventing superinfection—when bacteria, fungi, or other germs infect already damaged skin—is another important aspect of standard care. Using liquid antiseptics such as 0.05% chlorhexidine during bathing helps keep the skin clean. Topical dressings, including gauze or hydrocolloid dressings, protect vulnerable areas including genital regions.^[9]

For patients who experience recurrent episodes of erythema multiforme associated with herpes simplex virus infections, prophylactic antiviral therapy is recommended. Continuous treatment with oral acyclovir at doses of 200 mg once daily to 400 mg twice daily has been shown to be effective in reducing the frequency of recurrences, even when herpes infections are subclinical (not producing obvious symptoms). In children, a dose of 10 mg per kilogram of body weight per day may be considered. Prophylaxis may need to continue for six to twelve months or longer. If acyclovir doesn’t prevent recurrences, alternative antivirals such as valacyclovir (500 mg twice daily) or famciclovir (250 mg twice daily) may be tried.^[8][9][10]

Treatment in Clinical Trials

While standard treatments address most cases of erythema multiforme effectively, ongoing research continues to explore additional therapeutic options, particularly for patients with recurrent or persistent forms of the disease that don’t respond well to conventional approaches. Clinical trials have investigated various medications and interventions, though many are still in early phases of study or have been documented primarily in individual case reports rather than large-scale trials.^[10]

Alternative treatment options that have been documented in medical literature include several medications with different mechanisms of action. Dapsone (an antibiotic with anti-inflammatory properties) has been used in some cases. Antimalarial drugs such as hydroxychloroquine have also been tried, based on their immunomodulatory effects. Azathioprine (an immunosuppressant medication that reduces immune system activity) represents another option for cases that are difficult to control.^[9]

Cimetidine (a medication originally developed to reduce stomach acid) has shown beneficial effects in some patients with erythema multiforme, likely through its immunomodulatory properties. Case reports have documented successful outcomes with this approach, though larger controlled studies are needed to confirm its effectiveness.^[9]

More advanced therapeutic interventions have been explored in resistant cases. Thalidomide (a medication with anti-inflammatory and immunomodulatory effects) has been documented to provide benefits in some case reports. However, thalidomide carries significant risks, including severe birth defects if taken during pregnancy and peripheral neuropathy (nerve damage causing numbness and tingling), so its use is carefully restricted.^[9]

Apremilast (an oral medication that inhibits an enzyme called phosphodiesterase 4, which plays a role in inflammation) has been reported to benefit patients with recurrent erythema multiforme in case reports. This represents a newer approach targeting specific inflammatory pathways.^[9]

Adalimumab (a biologic medication that blocks tumor necrosis factor-alpha, or TNF-α, a protein involved in inflammation) has also been used in some cases documented in medical literature. Biologic therapies like adalimumab work by targeting specific components of the immune system, offering a more precise approach than broad immunosuppression. However, these medications carry risks including increased susceptibility to infections and potential for other immune-related complications.^[9]

Additional interventions that have been documented include cyclophosphamide (a powerful immunosuppressant), cyclosporin (another immunosuppressant that affects T-cell function), levamisole (an immune stimulant), and even procedures like hemodialysis, plasmapheresis (a process that filters blood to remove antibodies), and intravenous immunoglobulin (concentrated antibodies given intravenously). These approaches are typically reserved for the most severe, refractory cases and are administered under close medical supervision due to their potential for serious side effects.^[9]

For women who experience erythema multiforme linked to their menstrual cycle, a condition called premenstrual erythema multiforme, some reports suggest that tamoxifen (a medication that modulates estrogen receptors) may help prevent recurrences. This represents a highly specialized treatment for a specific subgroup of patients.^[9]

It’s important to note that while these various medications and procedures have been reported in medical literature, they are not considered standard first-line treatments. They are typically explored only when conventional approaches fail or when patients have particularly severe, recurrent disease that significantly impacts their quality of life. The decision to pursue any of these options involves careful consideration of potential benefits versus risks, and requires ongoing monitoring by healthcare providers with expertise in managing complex dermatological conditions.^[10]

Most common treatment methods

• Symptomatic relief and topical treatments
  • Topical corticosteroid creams or ointments to reduce inflammation and itching
  • Moisturizers to keep skin hydrated and promote healing
  • Antihistamines to control itching
  • Cold compresses with saline or Burrow solution to soothe irritated skin
  • Oral anesthetics such as viscous lidocaine or diphenhydramine elixir for mouth involvement
• Antiviral therapy
  • Prophylactic oral acyclovir (200-400 mg daily) to prevent recurrent herpes-associated erythema multiforme
  • Alternative antivirals including valacyclovir (500 mg twice daily) or famciclovir (250 mg twice daily) if acyclovir is ineffective
  • Treatment typically continued for 6-12 months or longer
• Systemic corticosteroids
  • Oral or intravenous steroids for severe cases, though use remains controversial
  • Typically limited to short courses of 10-14 days when prescribed
• Infection treatment
  • Appropriate antibiotics for bacterial infections such as Mycoplasma pneumoniae
  • Antiviral medications for documented viral infections
• Supportive care
  • Intravenous fluids and electrolyte replacement for severe cases with dehydration
  • Nutritional support when eating is difficult due to mouth involvement
  • Eye care including topical lubricants, antibiotic solutions, and ophthalmologic consultation for ocular involvement
  • Liquid antiseptics like 0.05% chlorhexidine during bathing to prevent superinfection
  • Topical dressings (gauze or hydrocolloid) for genital involvement
• Alternative medications for refractory cases
  • Dapsone, azathioprine, antimalarial drugs, cimetidine, thalidomide, apremilast, adalimumab, cyclophosphamide, cyclosporin, or levamisole
  • Advanced procedures including plasmapheresis, hemodialysis, or intravenous immunoglobulin
  • Tamoxifen for premenstrual erythema multiforme